eligible to hold graduate school appointments in the Gerstner Sloan Kettering Graduate School of Biomedical Sciences, the Weill Graduate School of Medical Sciences of Cornell University, as well as the Tri-Institutional MD/PhD Training Program and Tri-Institutional Training Program in Chemical Biology.
Memorial Sloan Kettering Cancer Center (MSK) offers a unique and exciting research environment with programs in Immunology, Pharmacology, Chemistry, Molecular Biology, Computational Biology, Genetics, Cell Biology, Developmental Biology, Cellular Biochemistry, Structural Biology, and Human Oncology and Pathogenesis. The presence of world-renowned clinical programs in cancer research, treatment, and prevention offers unique opportunities for creative collaboration.
Applicants should have a PhD and/or MD degree, postdoctoral experience, and dedication to important problems at the interface of biology, biochemistry, or chemistry as they relate to cancer pharmacology or innovative therapeutics.
The deadline for applications is October 1, 2026. Interested candidates should visit https://facultysearch.ski.edu to access the on-line faculty application. Please visit the site as soon as possible, as it contains important information about the required application materials, including deadlines for submitting letters of reference.
Inquiries may be sent to Maria Torres at torresm2@mskcc.org
Salary range for these positions is $195,000–$260,000. Starting pay for new hires typically falls within the range shown above, based on candidate qualifications and experience, as well as other variables. This range represents annual salary only and does not include any one-time payments that eligible candidates may be offered at the time of hire. Memorial Sloan Kettering Cancer Center is an equal opportunity and affirmative action employer committed to diversity and inclusion in all aspects of recruiting and employment. All qualified individuals are encouraged to apply.
Company
The Sloan Kettering Institute (SKI) is a hub for basic and translational research within Memorial Sloan Kettering Cancer Center. SKI is focused on the pursuit of fundamental scientific discoveries. The institute’s philosophy is that the best way to fuel progress in cancer treatment is to support scientists as they explore the unknown. Collaboration is a hallmark of the research enterprise at SKI. Our scientists collaborate across programs, across disciplines, and across institutions. Discoveries made in SKI labs are an important driver of clinical progress at MSK and beyond.
